The MarketWatch News Department was not involved in the creation of this content.
April 28, 2023 (Market Insights Reports) -- Los Angeles, CA Zion Market Research recently published a research reportGlobal Oncology Information System Market Sizeilluminate significant developments and the powerful gun in the evolution of trade, including growth, restraints, market drivers and opportunities. The report deals with the competitive landscape prevailing in the Oncology Information Systems market across the globe. The report provides an overview of the major players in the market and also provides insightful information about them such as their business overview, product segmentation, and revenue segmentation. Annual estimates and forecasts are provided for the period from 2017 to 2022. A six-year historical analysis is also provided for the Oncology Information Systems markets. Market data and analysis are derived from primary and secondary research. Company profiles are mostly based on information from the public domain.
Our team of experts provides you with a free sample PDF copy of the Industry Growth and Development Factors Research Report:https://www.zionmarketresearch.com/sample/oncology-information-system-market
What free sample report does it include?
The authors of the report have segmented the global oncology information system market by vendor list, product, application, and region. Segments of the global Oncology Information System market are analyzed on the basis of market share, production, consumption, revenue, CAGR, market size, and other factors. Analysts have characterized the leading industry players in the Universal Oncology Information System market by keeping an eye on their recent developments, market revenue, shares, revenue, product portfolio, areas covered, and other aspects.
Top players include Overview, Financials, Product Portfolio, Business Strategy and Recent Developments:
Koninklijke Philips N.V., Accuray Inc., McKesson Corporation, Flatiron Health Inc., Epic Systems Corporation, Cerner Corporation
The research objectives of this report are:
- To analyze and study the Global Oncology Information System market capacity, production, value, consumption, status (2013-2017) and forecast (2022-2030);
- Spotlights on the key drivers of the Oncology Information Systems market to examine limits, creation, value, piece of the overall industry and development plans future.
- Spotlights on the overall key makers, in order to characterize, describe and break down the market rivalry, SWOT investigation.
- Characterize, display and evaluate the market by type, application and location.
- To examine global and key areas of market potential and preferred positions, opportunities and challenges, restraints and threats.
- Discover critical patterns and factors that drive or suppress market development.
- Examine the changes within the partner mall by highlighting the highly developed parts.
- Deliberately analyze each submarket with respect to a specific design and their commitment to the market
- Investigate serious developments such as developments, deals, new item deliveries and acquisitions within the market
- Intentionally profile people in focus and thoroughly dissect their improvement techniques.
How can data be collected?With all the information gathered and researched using the SWOT analysis, a vivid picture of the competitive landscape of the global Oncology Information Systems market emerges. Opportunities for future market development are revealed and competitive risks of competition are also structured. The movement and trend of this market has been observed and illustrates that excellent strategic oversight has been observed. By understanding market fundamentals and using the established excellence, methodologies and tendencies of other floating markets as a reference, market statistics are understood.
What are the different regions covered in this report in terms of product types and their usage?
Globally, the global Oncology Information System market is fragmented into various regions such as North America, Latin America, Middle East, Asia Pacific, Africa and Europe. Additionally, it provides a holistic overview of the competitive landscape across the globe. In order to get a better insight into companies, it offers different strategies and methodologies. The Global Oncology Information Systems Market is presented in a clear, concise and professional manner that helps in better understanding of the readers.
Included in the report are several infographics that provide a graphical representation of some key market facts and figures.
North America:USA, Canada, Rest of North America
Europa:Great Britain, Germany, France, Italy, Spain, Rest of Europe
Asia Pacific:China, Japan, India, Southeast Asia, Rest of Asia Pacific
Latin America:Brazil, Argentina, the rest of Latin America
Middle East and Africa:GCC countries, South Africa, the rest of the Middle East and Africa
Points covered in the report:Global Oncology Information System Market 2021 studies provide a primary overview of the business including definitions, classifications, programs and industry chain structure. Global Oncology Information System Market analysis is provided for the global markets including improvement developments, competitive landscape assessment, and key areas development status. Development policies and plans are discussed, along with production procedures and value systems. This document also lists import/export consumption, supply and recall figures, value, price, sales and gross margins.
Segments by species: software and professional services
Segments by application:Medical oncology, surgical oncology and radiation oncology
2. ChapterIndustry cost structure and economic performance
Chapter 3Rising trends and emerging technologies with profiles/analysis of major manufacturers
Chapter 4Global Oncology Information System Market Analysis, Trends, Growth Factor, Porter's Five Forces Analysis
chapter 5Oncology information system Market offer (production), consumption, export, import and business with analysis of potential by region
Chapter 6Global Oncology Information System Market Production, Revenue (Value), Price Trend by Type and Application
chapter 7Marketing strategy analysis, distributors/representatives
Chapter 8Industrial demand supply chain, procurement strategy and downstream customers
Chapter 9Analysis development trend, market performance factor analysis
Chapter 10Research findings and conclusion
Who can buy this report?
- Consulting companies and research institutes
- Industry leaders and companies plan to enter the university and student oncology information systems market
- Service providers, product providers, solution providers and other players in the Small Modular Reactor (SMR) market.
- Government agencies and related private companies
- People were intrigued to know more about the Oncology Information System market
Reason for buying the report / why buy the report?
|Base year for assessment||2022|
|Actual estimates/historical data||2016 – 2022|
|Estimated period||2022 - 2030|
|Market representation||Revenue in USD Million/Billion & CAGR from 2022 to 2030|
|Regional reach||North America, Europe, Asia Pacific, Central and South America and MEA|
|Reach across the country||USA, Germany, UK, Italy, China, Japan, Brazil|
|Coverage report||Revenue forecast, company size and share, competitive landscape, growth drivers and trends|
|Free adjustment range (equivalent to 5 analyst working days)||If you need specific information, which is not currently in the scope of the report, we will provide it to you as part of the customization|
The integration of graphic data, examples, charts, diagrams and tables in the report makes it clear and understandable for professionals and laymen alike. The Oncology Information System Market report helps in making customer-centric business decisions by providing a comprehensive view of the market with consequential information. The key weaknesses and strengths of the leading vendors along with the growth rate for each segment of the global Oncology Information Systems market have been awarded after a comprehensive review of current and future trends, regulatory requirements, and technological advancements.
Get a detailed report @https://www.zionmarketresearch.com/report/oncology-information-system-market
The following is a brief summary of the study's various factual statements:
- There is a section in this report that lists strategic developments for major industry players, further broken down into existing and upcoming R&D developments, latest product launches and collaborations, as well as regional growth and mergers and acquisitions.
- The study deals with valuable market characteristics such as turnover, product cost, capacity and occupancy rates, import/export rates, supply/demand figures, market share and CAGR.
- The investigation consists of a combination of analytical tools and an internal internal investigation process.
For more information feel free to ask any question about market situations, challenges you want, our research team will always help you 24X7 @firstname.lastname@example.org
ALSO READ OUR TRENDING TOP SELLER REPORTS:
Exploring the Zion market is a must. We produce futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We not only provide our clients with market statistics revealed by recognized private publishers and public organizations, but also trending and latest industry reports along with profiles of leading and niche companies. Our market research report database contains a large selection of reports from major industries. Our database is constantly updated to provide our customers with fast and direct online access to our database. With customer needs in mind, we have included expert insights on global industries, products and market trends in this database. Last but not least, it is our duty to ensure the success of the clients associated with us - after all - when you do it right, some light shines on us.
Is there a problem with this press release? Contact resource provider Comtex email@example.com. You can also contact MarketWatch Customer Service through ourCustomer Center.
The MarketWatch News Department was not involved in the creation of this content.
How big is the oncology market in 2030? ›
The global oncology market was valued at US$ 286.04 billion in 2021 and is expected to reach over US$ 581.25 billion by 2030, poised to grow at a noteworthy CAGR of 8.2% from 2022 to 2030.What are the segments of the oncology market? ›
The global oncology drugs market is segmented on the basis of drug class type, indication, and region. Depending on drug class type, the market is divided into chemotherapy, targeted therapy, immunotherapy (biologic therapy), and hormonal therapy.What is currently the oncology market size? ›
Global Oncology Market is valued at USD 305.07 Billion in 2022 and is projected to reach a value of USD 556.35 Billion by 2030 at a CAGR (Compound Annual Growth Rate) of 7.80% over the forecast period.What is the market share of oncology drugs? ›
KEY MARKET INSIGHTS
Oncology is a key driver for the growth of the pharmaceutical industry. It is estimated to account for about 30 percent of its product pipeline and 25 percent of pharmaceutical industry revenue by 2020.
The future of oncology will be shaped by precision medicine and better technology. Gene therapy, machine learning, and reimbursement changes will modify how community oncology programs function. In addition, many oncology centers will need to adopt new measures to manage patients who expect to be treated as consumers.What is the size of the oncology market 2025? ›
The market is expected to reach $112.14 billion in 2025 at a CAGR of 7%.What are the 4 major market segments? ›
The 4 main types of market segmentation include demographic, geographic, psychographic, and behavioral–which we'll cover more in depth in the next section. An example of a marketing segmentation variable would be age.What are the 5 main market segments? ›
Five ways to segment markets include demographic, psychographic, behavioral, geographic, and firmographic segmentation.What are the 4 main segments of the market? ›
Demographic, psychographic, geographic, and behavioral are the four pillars of market segmentation, but consider using these four extra types to enhance your marketing efforts.What is the market share of oncology in the US? ›
North America Market, By Cancer Diagnostics & Treatment
The cancer treatment segment dominated over 57% market share in 2021, attributed to increasing disposable income and rising awareness by government for the early-stage diagnosis and treatment of cancer.
Who are one oncology competitors? ›
- Meduit. Healthcare - Private.
- Artera. Healthcare - Private.
- Isabl. Healthcare - Private.
- American HealthTech. Healthcare - Private.
Who are Oncology Supply 's competitors? Alternatives and possible competitors to Oncology Supply may include Taiho Oncology , Laboratorios Stein , and Molecular Insight Pharmaceuticals .Who are US oncology Network competitors? ›
US Oncology competitors include Genzyme, Pfizer and ac.What is the future supply and demand for oncologists? ›
Demand for oncology services is expected to rise rapidly, driven by the aging and growth of the population and improvements in cancer survival rates, at the same time the oncology workforce is aging and retiring in increasing numbers. Demand is expected to rise 48% between 2005 and 2020.What is the largest oncology association? ›
The American Society of Clinical Oncology (ASCO) is the world's leading professional organization representing physicians who care for people with cancer. With more than 30,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals.What are the trends in oncology 2023? ›
Approximately 2 million new cancers are expected in 2023, with prostate, lung, and colorectal cancer (CRC) as the leading diagnoses in men (combined 48%), and breast, lung, and CRC accounting for 52% of diagnoses in women.What are the biggest problems in oncology? ›
Upon hearing a diagnosis of cancer, the patient is faced with a multitude of issues. In addition to the medical and logistic details described previously, major concerns include fear of death, disfigurement, pain, disability, infertility, dependency, abandonment, altered relationships, and financial hardship.Is oncology a growing field? ›
The oncology market continues to expand at a rapid pace. Experts expect ongoing increases in cancer diagnoses over the next 10 years. Most of these increases will result from an aging population.What is the market size for oncology in 2027? ›
|Oncology Market in India: Scope|
|Market growth 2023-2027||USD 947.84 million|
|YoY growth 2022-2023 (%)||12.42|
Analyst consensus figures indicate a robust 12 percent compound annual growth rate (CAGR), and global oncology therapeutics sales are forecasted to hit $250 billion by 2024.
What is next for oncology care model? ›
The Centers for Medicare & Medicaid Services (CMS) has announced a new, voluntary alternative payment model, which will replace the Oncology Care Model (OCM) that ended on June 30. The OCM's successor, known as the Enhancing Oncology Model (EOM), will begin next year on July 1, and run for 5 years.What are the 6 areas of market segmentation? ›
This is everything you need to know about the 6 types of market segmentation: demographic, geographic, psychographic, behavioural, needs-based and transactional.What is the 8 P's of marketing? ›
The 8 Ps of marketing is product, price, place, promotion, people, positioning, processes, and performance. The goal is to get them working together for your marketing mix. If you can you'll have a much better chance to attract and convert your potential customers. There's no shortage of marketing advice out there.What are four 4 key ways to identify a target audience? ›
Geographic, demographic, psychographic and behavioral are the four levels of segmentation that can help define your business's primary target audience.What are the 8 types of market segmentation? ›
Read this article to learn about the eight important bases for segmentation of market, i.e., (1) Geographic Segmentation, (2) Demographic Segment, (3) Economic Segmentation, (4) Psychological/Psychographic Segmentation, (5) Sociocultural Segmentation, (6) Use Related Segmentation, (7) Benefits Segmentation, and (8) ...What are the 6 factors under the demographic segmentation? ›
Demographic segmentation in marketing refers to dividing a market or consumer base into distinct groups based on demographic factors such as age, gender, education, income, ethnicity, and family status, enabling targeted marketing efforts and tailored product or service offerings.What are the 4 market concept? ›
The marketing concept rests on four pillars: target market, customer needs, integrated marketing and profitability.What are the 4 steps of market segmentation explain? ›
The process of market segmentation consists of 5 steps: 1) group potential buyers into segments; 2) group products into categories; 3) develop market-product grid and estimate market sizes; 4) select target markets; and 5) take marketing actions to reach target markets.What are market segmentation strategies? ›
A marketing segmentation strategy helps determine which customers you can build relationships with, how to group them, and what marketing actions to take to best reach your target market. Creating a customized experience catered to customers lead to higher customer retention rates and more focused marketing campaigns.How competitive is medical oncology? ›
Oncology fellowship programs are highly competitive and require a high level of dedication to attend. Once you've completed your oncology fellowship, you can complete the American Board of Internal Medicine (ABIM) exam for board certification.
What is the market size for immune oncology? ›
The Global Immuno Oncology Market Size was valued at USD 26.6 Billion in 2021 and the worldwide biotechnology market is expected to reach 154.57 USD Billion by 2030, According to a research report published by Spherical Insights & Consulting.What are the top oncology drugs by revenue? ›
- Imbruvica. ...
- Darzalex. Revenues: $8.0 billion. ...
- Opdivo. Revenues: $8.2 billion. ...
- Tagrisso. Revenues: $5.5 billion. ...
- Ibrance. Revenues: $5.1 billion. ...
- Perjeta. Revenues: $4.4 billion. ...
- Tecentriq. Revenues: $4.0 billion. ...
- Pomalyst/Imnovid. Revenues:$3.5 billion.
Who are Elevation Oncology 's competitors? Alternatives and possible competitors to Elevation Oncology may include Resilience , Arcellx , and Alto Neuroscience .What is the 1 oncology hospital in the US? ›
The best cancer hospitals in the United States include The University of Texas MD Anderson Cancer Center, the Memorial Sloan Kettering Cancer Center, and the Mayo Clinic.Who bought US oncology? ›
McKesson Acquires US Oncology Services for US$2.16 Bil.Who is the parent company of targeted oncology? ›
Targeted Oncology™ is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America, dedicated to delivering trusted health care news across multiple channels.Is there a shortage of oncology providers? ›
Why is there a shortage of oncologists? A dearth of young oncologists is driving the looming oncologist shortage. According to ASCO, approximately 1 in 5 practicing oncologists is nearing retirement age – and only 14.5% of cancer physicians are early-care oncologists.Who is Oncology Supply owned by? ›
Founded in service of oncology practices
A simple conversation about selling directly to physicians inspires Bill Stickler to found Oncology Supply, the first oncology distribution company in history. That year, we stock just 10 items.
- Cornell University.
- University of California San Francisco.
- University of Toronto.
- Yale University.
- University of California Los Angeles.
- Universite Paris Saclay.
- Vanderbilt University.
- University of Pennsylvania.
The main competitors of Guardant Health include Veracyte (VCYT), RadNet (RDNT), Viridian Therapeutics (VRDN), Fulgent Genetics (FLGT), Natera (NTRA), TransMedics Group (TMDX), Immunovant (IMVT), Amedisys (AMED), LivaNova (LIVN), and Corcept Therapeutics (CORT). These companies are all part of the "medical" sector.
Who are Med Pro competitors? ›
MedPro's competitors include Physicians Protector Plan, Wellness Medical Protection Group. MedPro ranks 1st among 3 active competitors.What is the future of radiation oncology? ›
After factoring in the growing number of Medicare beneficiaries and increasing productivity per radiation oncologist, the investigators projected that there will most likely be a relative balance between radiation oncologist supply and demand for radiation therapy services through 2030.Will oncologists be needed in the future? ›
The study found that the United States will likely face a 48% increase in demand for oncologist services by 2020—in large part because of the expected 81% increase in cancer survivorship and the 48% increase in cancer incidence caused by the aging of the population.What technology do oncologists use? ›
Technologies and innovations like CRISPR, artificial intelligence, telehealth, the Infinium Assay, cryo-electron microscopy, and robotic surgery are helping accelerate progress against cancer.What is the new name for 21st century oncology? ›
21st Century Oncology, now GenesisCare, collaborates with Landmark Cancer Center.How many oncology centers are there in the US? ›
Find an NCI-Designated Cancer Center
Find a center near you and learn about its specific research capabilities, programs, and initiatives. There are 71 NCI-Designated Cancer Centers, located in 36 states and the District of Columbia, that are funded by NCI to deliver cutting-edge cancer treatments to patients.
Some cities are flush with oncologists; however, 32 million Americans live in a county with no oncologists. ASCO projects a shortage for more than 2,200 oncologists by 2025.What is the projected supply of and demand for oncologists? ›
Without consideration of the Affordable Care Act (ACA), overall demand for oncologist services is projected to grow 40% (21,255 FTEs), whereas supply may grow only 25% (18,997 FTEs), generating a shortage of 2,258 FTEs in 2025.What is the market size for telemedicine in 2030? ›
What is the global telehealth market growth? b. The global telehealth market is expected to grow at a compound annual growth rate of 24.0% from 2023 to 2030 to reach USD 455.26 billion by 2030.What is the oncology market? ›
Oncology Drugs Definition
This industry includes establishments that produce drugs used in chemotherapy, surgery and radio therapies for treating pancreatic cancer, breast cancer, ovarian cancer, gastric cancer, kidney cancer, brain tumor, and other cancer types.
What is the highest paid oncologist? ›
- Hematologist Oncologist. Salary range: $391,500-$400,000 per year. ...
- MOHS Surgeon. Salary range: $120,000-$400,000 per year. ...
- Radiation Oncologist. Salary range: $400,000-$400,000 per year. ...
- Surgical Oncologist. Salary range: $285,000-$350,000 per year. ...
- Pediatric Oncologist. ...
- Oncology Social Worker.
“One area to watch for new developments in 2023 is the dynamic monitoring of the whole cancer journey, from detection to interception to monitoring of resistance in metastatic cancer, using new technologies, such as circulating tumor DNA (ctDNA) and other circulating biomarkers.What is an oncology target? ›
Targeted therapy is a type of cancer treatment that uses drugs designed to "target" cancer cells without affecting normal cells. Cancer cells typically have changes in their genes that make them different from normal cells. Genes are part of a cell's DNA that tell the cell to do certain things.What are the predictions for healthcare in 2030? ›
- Wearable technology monitors patient health. ...
- Genetic testing and genomic profiling are widely used. ...
- Telehealth is used for initial primary care appointments. ...
- Increased access to health analytics. ...
- Improved health outcomes.
Revenue in the Health Care segment is projected to reach US$60.72bn in 2023.What is the market size for healthcare technology? ›
The global healthcare IT market size was valued at USD 167.7 billion in 2022 and is projected to exhibit a CAGR of 17.9% in the forecast period.